EcoDrugPlus

Adenosine A1 Receptor

Ensembl ID : ENSOJAG00000013961
Gene Symbol: ADORA1
1 Cross references
204 Possible Orthologues:

Adenosine A1 Receptor B

Ensembl ID : ENSOJAG00000012463
Gene Symbol: ADORA1B
1 Cross references
173 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSOJAG00000018951
Gene Symbol: ADORA2A
1 Cross references
198 Possible Orthologues:

Adenosine A2a Receptor A

Ensembl ID : ENSOJAG00000013663
Gene Symbol: ADORA2AA
1 Cross references
189 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSOJAG00000017046
Gene Symbol: ADORA2B
1 Cross references
199 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSOJAG00000000407
Gene Symbol: ADA
1 Cross references
216 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSOJAG00000001363
Gene Symbol: ADRA1AA
1 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSOJAG00000007903
Gene Symbol: ADRA1B
1 Cross references
193 Possible Orthologues:

Adrenoceptor Alpha 1bb

Ensembl ID : ENSOJAG00000009936
Gene Symbol: ADRA1BB
1 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSOJAG00000005139
Gene Symbol: ADRA1D
1 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSOJAG00000001381
Gene Symbol: ADRA2A
1 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSOJAG00000016250
Gene Symbol: ADRA2A
1 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).